Evaluation of Reporting of Antibody-Drug Conjugate Associated Sepsis-related Toxicities

NCT05349383 · clinicaltrials.gov ↗

COMPLETED

Status

24618

Enrollment

OTHER

Sponsor class

Conditions

Sepsis (SMQ)
Opportunistic Infections
Agranulocytosis

Interventions

DRUG: Antibody-Drug Conjugate
DRUG: Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate

Sponsor

Central South University